Results 221 to 230 of about 6,119,378 (259)

Autologous hematopoietic stem cells transplantation in MOGAD

Multiple Sclerosis Journal
[no abstract available]
Mariotto, Sara, Carta, Sara
openaire   +3 more sources

Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis

Current Stem Cell Research & Therapy, 2011
Systemic sclerosis is a rare disorder manifesting as skin and internal organ fibrosis, a diffuse vasculopathy, inflammation, and features of autoimmunity. Patients with diffuse cutaneous disease or internal organ involvement have a poor prognosis with high mortality. To date no therapy has been shown to reverse the natural course of the disease. Immune
Francesca, Milanetti, Jurate, Bucha, Alessandro, Testori, Richard K, Burt   +3 more
openaire   +2 more sources

Autologous hematopoietic stem cell transplantation in autoimmune diseases

Expert Review of Hematology, 2009
The term 'autoimmune diseases' encompasses a spectrum of diseases whose clinical manifestations and, possibly, biological features vary widely. The results of conventional treatment are considered unsatisfactory in aggressive forms, with subsets of patients having short life expectancies.
C. Annaloro, F. Onida, G. Lambertenghi Deliliers   +2 more
openaire   +3 more sources

Factors affecting stem cell mobilization for autologous hematopoietic stem cell transplantation

Journal of Clinical Apheresis, 2010
AbstractHigh‐dose chemotherapy with autologous stem cell transplantation (ASCT) is curative treatment in various hematologic malignancies. Mobilization and collection of peripheral blood stem cell is the essential part of ASCT. The aim of this study was to evaluate the effectiveness of various mobilization regimens, determine the risk factors ...
YEGİN, ZEYNEP ARZU, Aki, Sahika Zeynep, Acar, Kadir, Sucak, Gulsan Turkoz, Yagci, Munci, ÖZKURT, ZÜBEYDE NUR, Suyani, Elif   +6 more
openaire   +3 more sources

[Autologous hematopoietic stem cell transplantation].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 2009
Currently, autologous hematopoietic stem cell (SCT) transplantation is frequently used as a method of treatment for various hematologic malignant neoplasms and some solid tumors in adults and children. Autologous stem cells can be obtained in most instances from the patient's bone marrow or peripheral blood.
openaire   +3 more sources

Autologous hematopoietic stem cell transplantation in multiple sclerosis

Neurology, 2017
To summarize the evidence on immunoablative therapy followed by autologous hematopoietic stem cell transplantation (aHSCT) to manage severe and treatment-refractory multiple sclerosis (MS).We collected all the published studies of aHSCT in any form of MS from 1995 to 2016, carefully excluding reports that were updated in subsequent studies.
Sormani, Maria Pia, Muraro, Paolo A., Schiavetti, Irene, Signori, Alessio, Laroni, Alice, Saccardi, Riccardo, Mancardi, Gian Luigi, Capello, E., Uccelli, A., Bagigalupo, F., Repice, A. M., Portaccio, E., Barillaro, A., Russo, C., De Luca, Giovanna, Farina, D., Tartaro, A., Blanco, Y., Berenguer, J., Bresciani, P., Cuoghi, A., Zonari, P.   +21 more
openaire   +3 more sources

Hyperthyroidism as a latent complication of autologous hematopoietic stem cell transplantation

International Journal of Hematology, 2008
Thyroid dysfunction after hematopoietic stem cell transplantation has been investigated in many studies. Most post-transplant thyroid disorders such as hypothyroidism are recognized as a late complication whilst hyperthyroidism is infrequent and transient, and usually happens early at the onset after transplant.
Yin-Hsun, Feng, Bo-An, Su, Cheng-Yao, Lin, Wen-Tsung, Huang, Chao-Jung, Tsao   +4 more
openaire   +2 more sources

Autologous hematopoietic stem cell transplantation for Crohn's disease

Autoimmunity Reviews, 2002
The feasibility and early experience of hematopoietic stem cell transplantation for severe Crohn's disease (CD) are discussed. The natural history, therapy, and evidence for autoimmunity of CD are outlined and related to this new therapy in terms of morbidity and mortality.
openaire   +2 more sources

Autologous and allogeneic hematopoietic stem cell transplantation in follicular lymphoma

Expert Opinion on Biological Therapy, 2015
High-dose chemotherapy and autologous stem cell transplantation (ASCT) improve survival in follicular lymphoma; however, relapse remains the most common cause of death. The lower risk of relapse with allogeneic SCT (alloSCT) is offset by a high transplant-related mortality (TRM).English articles indexed in the MEDLINE database were reviewed to discuss ...
V R, Bhatt, J O, Armitage
openaire   +2 more sources

Autoimmune disease after autologous hematopoietic stem cell transplantation

Autoimmunity Reviews, 2008
Hematopoietic stem cell transplantation (HSCT) is an effective treatment for refractory autoimmune diseases. The safety and long-term outcome have been also acceptable. Infectious diseases under immune suppressive state after autologous HSCT are common transplantation related complications whereas autoimmune diseases are uncommon.
Toshiyuki, Bohgaki, Tatsuya, Atsumi, Takao, Koike   +2 more
openaire   +2 more sources